ShareThis Page
Pittsburgh firm contributes capital for medical hemp industry |

Pittsburgh firm contributes capital for medical hemp industry

Stephen Huba
Dan Speicher | Tribune-Review
CBD oil is displayed for sale at Bella Unique Boutique in Greensburg.

Primal Equity, a Chicago-based investment advisory firm with offices in Pittsburgh, is raising capital for the Oregon-based medical hemp producer 4TF Investments.

The capital will go directly toward one of the largest medical-grade hemp harvests to date and will help the cannabidiol, or CBD, market continue to grow, said Joseph Kirkpatrick, associate principal of Primal Equity Partners.

4TF, based in Medford, Ore., is set to harvest 2,000 acres of medical-grade hemp from a network of hemp farms in multiple states for CBD use. CBD oil, a plant extract of hemp, is valued as a vitamin supplement and for other purported medical benefits.

Although the same species of plant as marijuana, hemp is mainly grown for fiber, seed and oil.

“4TF is positioned to be a top player in the industry,” said 4TF CFO Jeffery Yarosz. “We have the ability to produce medical-grade hemp on a large scale, as opposed to industrial grade. Industrial grade is the majority of hemp currently being grown in the United States.”

The 2018 Farm Bill made industrial hemp legal on a federal level. According to analysts, hemp is projected to be a $20 billion industry by 2022.

Both hemp and marijuana come from the same cannabis species but are genetically distinct and are further distinguished by use, chemical makeup and cultivation methods.

Hemp can be grown as a renewable source for raw materials that can be incorporated into thousands of products. Its seeds and flowers are used in health foods, organic body care and other nutraceuticals.

Stephen Huba is a Tribune-Review staff writer. You can contact Stephen at 724-850-1280, [email protected] or via Twitter .

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.